View in EDS HTML Full Text PDF Full Text

Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma-a promising innovative approach.

Saved in:
Bibliographic Details
Title: Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma-a promising innovative approach.
Authors: Gesundheit B; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Brauns C; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Vogl TJ; Department of Radiology and Nuclear Medicine, Frankfurt University Hospital, Frankfurt am Main, Germany., Muckenhuber A; Institute of Pathology, Technical University of Munich, Munich, Germany., Weisslein C; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Schmoll H; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Ellis R; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Posen Y; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Raju JS; Research and Development, RapoYerape Ltd., Jerusalem, Israel.
Source: Frontiers in oncology [Front Oncol] 2025 Aug 07; Vol. 15, pp. 1631155. Date of Electronic Publication: 2025 Aug 07 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40852481
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma-a promising innovative approach.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gesundheit+B%22">Gesundheit B</searchLink>; Research and Development, RapoYerape Ltd., Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Brauns+C%22">Brauns C</searchLink>; Research and Development, RapoYerape Ltd., Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Vogl+TJ%22">Vogl TJ</searchLink>; Department of Radiology and Nuclear Medicine, Frankfurt University Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Muckenhuber+A%22">Muckenhuber A</searchLink>; Institute of Pathology, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Weisslein+C%22">Weisslein C</searchLink>; Research and Development, RapoYerape Ltd., Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Schmoll+H%22">Schmoll H</searchLink>; Research and Development, RapoYerape Ltd., Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Ellis+R%22">Ellis R</searchLink>; Research and Development, RapoYerape Ltd., Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Posen+Y%22">Posen Y</searchLink>; Research and Development, RapoYerape Ltd., Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Raju+JS%22">Raju JS</searchLink>; Research and Development, RapoYerape Ltd., Jerusalem, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Aug 07; Vol. 15, pp. 1631155. <i>Date of Electronic Publication: </i>2025 Aug 07 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40852481
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1631155
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1631155
    Titles:
      – TitleFull: Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma-a promising innovative approach.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gesundheit B
      – PersonEntity:
          Name:
            NameFull: Brauns C
      – PersonEntity:
          Name:
            NameFull: Vogl TJ
      – PersonEntity:
          Name:
            NameFull: Muckenhuber A
      – PersonEntity:
          Name:
            NameFull: Weisslein C
      – PersonEntity:
          Name:
            NameFull: Schmoll H
      – PersonEntity:
          Name:
            NameFull: Ellis R
      – PersonEntity:
          Name:
            NameFull: Posen Y
      – PersonEntity:
          Name:
            NameFull: Raju JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 08
              Text: 2025 Aug 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1